Bristol-Myers Squibb Co at Jefferies Healthcare Conference Transcript
All right. Good morning, everyone. Thank you for joining us Day 2 of the Jefferies Healthcare Conference here in beautiful Times Square. I -- for those who don't know me, my name is Akash Tewari. I'm a pharma and biotech analyst here at Jefferies, and I have the pleasure of hosting Bristol and the new Chief Commercialization Officer, Adam Lenkowsky, who is going to join us for a fire-side chat.
Questions & Answers
I think, Adam, maybe just to start off as we get into Q&A, it's funny. If you always -- I always read pharma transcripts from 5 years ago or slide decks from companies and whatever seems to be the biggest debate that everyone's convinced is going to drive the stock over the next 5 years, never ends up actually because it was important. And you come into this role, this is a company where the new product launches are just so critical. And I feel like the way Wall Street looks at everything it's so binary, right?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |